DCBO Financials

Income Statement
MetricQ1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Revenue
41.5M
+6.4%
39.0M
+5.4%
37.0M
+5.8%
34.9M
+9.0%
32.1M
Cost of Revenue
8.1M
+7.3%
7.5M
+5.1%
7.1M
+2.3%
7.0M
+6.5%
6.6M
Gross Profit
33.4M
+6.2%
31.4M
+5.4%
29.8M
+6.7%
28.0M
+9.6%
25.5M
Operating Expenses
33.7M
+8.8%
31.0M
-0.2%
31.0M
+1.0%
30.7M
+5.9%
29.0M
R&D
7.4M
+15.7%
6.4M
+4.5%
6.1M
-0.1%
6.1M
-1.2%
6.2M
SG&A
25.6M
+6.7%
24.0M
-1.5%
24.3M
+1.4%
24.0M
+8.1%
22.2M
Operating Income
-274000
-156.0%
489.0K
+141.1%
-1190000
+56.7%
-2747000
+21.0%
-3479000
EBITDA
433.0K
-11.5%
489.0K
+178.1%
-626000
+71.0%
-2160000
+25.5%
-2899000
Net Income
1.2M
-22.2%
1.6M
-84.4%
10.3M
+388.5%
2.1M
+130.2%
-6959000
EPS (Basic)
$0.04
-20.0%
$0.05
-83.9%
$0.31
+416.7%
$0.06
+128.6%
$-0.21
EPS (Diluted)
$0.04
-20.0%
$0.05
-83.3%
$0.30
+400.0%
$0.06
+128.6%
$-0.21
Shares (Diluted)
34.2M
-2.6%
35.1M
+2.9%
34.1M
+0.1%
34.0M
+3.0%
33.0M
Docebo Inc. Common Shares (DCBO) โ€” Financials